Children born to mothers who took valproate while pregnant had an almost threefold increased risk of having an autism spectrum disorder, a Danish study found. In some mothers who took the epilepsy drug during their pregnancy, the risk of having a child with autism was more than four times greater. The findings, based on 656,000 children born in Denmark between 1996 and 2006, appear in the Journal of the American Medical Association.
Prenatal valproate exposure linked to increased autism risk
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|